Kounatidou, E., Nakjang, S., McCracken, S. R., Dehm, S. M., Robson, C. N., Jones, D., & Gaughan, L. (2019). A novel CRISPR-engineered prostate cancer cell line defines the AR-V transcriptome and identifies PARP inhibitor sensitivities. Nucleic Acids Res.
Citação norma ChicagoKounatidou, Evangelia, Sirintra Nakjang, Stuart R C McCracken, Scott M. Dehm, Craig N. Robson, Dominic Jones, and Luke Gaughan. "A Novel CRISPR-engineered Prostate Cancer Cell Line Defines the AR-V Transcriptome and Identifies PARP Inhibitor Sensitivities." Nucleic Acids Res 2019.
MLA citiranjeKounatidou, Evangelia, et al. "A Novel CRISPR-engineered Prostate Cancer Cell Line Defines the AR-V Transcriptome and Identifies PARP Inhibitor Sensitivities." Nucleic Acids Res 2019.